Werner Christie | |
---|---|
Minister of Health and Social Affairs | |
In office 4 September 1992 –22 December 1995 | |
Prime Minister | Gro Harlem Brundtland |
Preceded by | Position established |
Succeeded by | Gudmund Hernes |
Personal details | |
Born | Werner Hosewinckel Christie 26 April 1949 Norway |
Political party | Labour |
Werner Hosewinckel Christie (born 26 April 1949) is a Norwegian politician for the Labour Party. He was Norway's first Minister of Health from 1992 to 1995,serving in Gro Harlem Brundtland's third cabinet. [1]
Werner Christie was educated as a medical doctor (University of Oslo,1979). He also earned degrees in sociology from the University of Oslo in 1969,philosophy from the University of Bergen in 1971,and political science from the University of Oslo in 1972. [1] He also has more than 13 years experience as a part-time farmer.
Christie served as the first Chair of the steering group of the World Health Organization's Stop TB program (a global public-private partnership). He chaired the Biotechnology Advisory Board of Norway from 2000 to 2004.
He worked as a public health officer and hospital manager in Norway,and conducted research and published a textbook in the planning and management of primary health care. He served on a number of boards for health care providers,investors and start-ups,including the European Federation of Biotechnology and the ScanBalt biotechnology network. He spent five years as a special advisor to the Norwegian Trade Council,and served two years in that function in San Francisco (1999–2001). In 2007 he became a board member of Public Advice International Foundation. In 2008,Christie became a board member of EduMonde SA (an educational media venture) and a member of the Presidium of the United Nations' International Eco-Safety Cooperative Organization.
In 2001 he started his own full-time consulting business,World Health Connections,focusing on entrepreneurship and investment strategies in medical technology and biotechnology,as well as health care development and consulting. He was appointed in May 2004 as Science and Technology Counsellor for the Royal Norwegian Embassy in Beijing,China,where his work is mainly focused on energy,environmental,building,medical,marine and biological sciences and technologies as well as welfare and health reform issues.
Dagfinn Høybråten is a Norwegian politician. He was the leader of the Christian Democratic Party 2004–2011. He was also Parliamentary leader from 2005 when he was elected as Member of Parliament representing Rogaland. He was Vice President of the Norwegian Parliament from 2011 to 2013. He was President of the Nordic Council in 2007. Høybråten was granted leave from his duty as Member of Parliament from March 2013 to take up the position as Secretary General of the Nordic Council of Ministers. He was elected board member of the GAVI Alliance in 2006 and chair of the board from 2011 to 2015.
The Norwegian University of Life Sciences is a public university located in Ås,Norway. It is located at Ås in Viken,near Oslo,and at Adamstuen in Oslo and has around 5,200 students.
Calestous Juma was a Kenyan scientist and academic,specializing in sustainable development. He was named one of the most influential 100 Africans in 2012,2013 and 2014 by the New African magazine. He was Professor of the Practice of International Development and Faculty Chair of the Innovation for Economic Development Executive Program at Harvard Kennedy School. Juma was Director of the School's Science,Technology and Globalization Project at Harvard Kennedy School as well as the Agricultural Innovation in Africa Project funded by the Bill and Melinda Gates Foundation. His last book,Innovation and Its Enemies:Why People Resist New Technologies, was published by Oxford University Press in 2016.
The President's Council of Advisors on Science and Technology (PCAST) is a council,chartered in each administration with a broad mandate to advise the president of the United States on science and technology. The current PCAST was established by Executive Order 13226 on September 30,2001,by George W. Bush,was re-chartered by Barack Obama's April 21,2010,Executive Order 13539,by Donald Trump's October 22,2019,Executive Order 13895,and by Joe Biden's February 1,2021,Executive Order 14007.
Harvey Vernon Fineberg is an American physician. A noted researcher in the fields of health policy and medical decision making,his past research has focused on the process of policy development and implementation,assessment of medical technology,evaluation and use of vaccines,and dissemination of medical innovations. Fineberg has held several prominent positions over the course of his career,including Dean of the Harvard School of Public Health,Provost of Harvard University,and President of the Institute of Medicine,now the National Academy of Medicine.
Charles Thomas Caskey,also known as C. Thomas Caskey,was an American internist who has been a medical Geneticist and biomedical researcher and entrepreneur. He was a Professor of Molecular and Human Genetics at Baylor College of Medicine,and served as editor of the Annual Review of Medicine from 2001 to 2019. He was a member of the editorial boards of the Proceedings of the National Academy of Sciences,Science,the Encyclopedia of Molecular Medicine and numerous other medical and scientific journals.
Dan Koenig Morhaim is an American politician,physician,and author. He was a member of the Maryland House of Delegates representing northwest Baltimore County from 1995 to 2019. He sponsored legislation concerning healthcare,the environment,and streamlining government operations. As an author,Morhaim has written articles for medical publications and the general media at large.
Ralph Snyderman is a Chancellor Emeritus at Duke University,James B. Duke Professor of Medicine,and Executive Director of the Duke Center for Personalized Health Care. He served as chancellor for health affairs and dean of the School of Medicine from 1989 to July 2004. Under his leadership,Duke University created the Duke University Health System (DUHS) to develop and operate a comprehensive health delivery system,and he was its founding President and Chief Executive Officer. DUHS,with its practice networks,ambulatory care centers,home health services,community hospitals,university hospital,and satellite collaborations demonstrated the power of academic medicine to deliver the best of care to broad communities. Snyderman helped lead the creation of the largest academic clinical research organization worldwide. During his tenure,Duke University Hospital was ranked 6th overall in the nation and its medical school ranked 4th. Snyderman is a leader in the conception and development of personalized health care,an evolving model of national health care delivery. He has articulated the need to move the current focus of health care from the treatment of disease-events to personalized,predictive,preventive,and participatory care that is focused on the patient. As Senior Vice-President at Genentech,he led the development of powerful new molecular biology therapeutics. Ralph Snyderman was the recipient of the 2012 David E. Rogers Award from the Association of American Medical Colleges which recognized him as "The Father of Personalized Medicine." He is a member of the Association of American Medical Colleges,Association of American Physicians,American Academy of Arts &Sciences,and the National Academy of Medicine.
David L. Gollaher was the founding President &CEO of the California Healthcare Institute (CHI),1993–2014,from which he joined Gilead Sciences. Initially,in 1998,he was a charter member of Gilead's Health Policy Advisotry Board,then,from 2014 to 2018,he served as the company's head of worldwide Government Affairs and Policy. Subsequently,in early 2019,he was appointed Senor Vice President of global policy and government affairs at Vir Biotechnology,an emerging growth biotech company focused on infectious diseases. He retired from Vir in 2021. Previously,in 2018,he was named Senior Fellow at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California.
The Nordic Institute of Dental Materials AS(NIOM AS) is a Nordic Cooperative Body for dental biomaterials. The Institute’s activities in research,materials testing,standardisation and research-based consulting are directed towards dental health services and health authorities in the Nordic countries. The Institute is owned jointly by NORCE and the Norwegian Ministry of Health and Care Services. Activities are financed by the Nordic Council of Ministers and the Nordic ministries for health services. Materials testing and consulting services also generate income. As a joint Nordic resource center,NIOM collaborates with dental schools and research institutions and provides services to government health authorities,dental professionals,and the public in the Nordic countries in the field of dental biomaterials.
Søren Holm is a bioethicist and philosopher of medicine. He holds a chair in bioethics at the Centre for Social Ethics and Policy,part of the School of Law at the University of Manchester in Great Britain and the University of Oslo. With Professor John Harris Holm served as co-Editor in Chief of the Journal of Medical Ethics from 2004-2011. Holm holds a master's degree in health care ethics from the University of Manchester and two doctoral degrees in medical ethics from the University of Copenhagen. He was a member of the Nuffield Council on Bioethics from 2006 to 2012 and a member of the Council’s Working Party on Emerging biotechnologies.
Kåre Ingmar Berg,MD was a Norwegian professor in medical genetics,physician-in-chief and well-cited researcher.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill &Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California,San Francisco (UCSF),the first woman to hold the position,and Arthur and Toni Rembe Rock Distinguished Professor,and before that president of product development at Genentech,where she played a role in the development of the first gene-targeted cancer drugs,Avastin and Herceptin.
Camilla Stoltenberg is a Norwegian physician and researcher. Since 13 August 2012,she has been Director-General of the Norwegian Institute of Public Health. She is the sister of former Prime Minister of Norway and General Secretary of NATO,Jens Stoltenberg.
Norman Daniels is an American political philosopher and philosopher of science,political theorist,ethicist,and bioethicist at Harvard University and the Harvard T.H. Chan School of Public Health. Before his career at Harvard,Daniels had built his career as a medical ethicist at Tufts University in Medford,Massachusetts,and at Tufts University School of Medicine,also in Boston. He also developed the concept of accountability for reasonableness with James Sabin,an ethics framework used to challenge the healthcare resource allocation in the 1990s.
Stephen L. Ondra is the chief medical adviser for the MITRE Corporation’s work as operator of the CMS Alliance to Modernize Healthcare federally funded research and development center. Ondra advises all HHS organizations to advance private insurance markets,Medicare and Medicaid,value-based payments,and healthcare quality. Ondra was most recently CEO of Cygnus-AI Inc.,a company specializing in artificial intelligence and clinical decision support tools for diagnostic radiology. He was also founder and chief executive officer of North Star Health Care Consulting,and served on the board of directors of Triple-S Management and electroCore. A neurosurgeon and neuroscientist,Ondra has also served in senior positions in the Federal government,having a role in health reform efforts and the implementation of the Affordable Care Act. He advises corporations,provider organizations and early-stage start-ups on the transition to value-based care and health IT strategy.
Brett P. Giroir is an American pediatrician. He was formerly the U.S. assistant secretary for health,a four-star admiral in the U.S. Public Health Service Commissioned Corps and an acting Food and Drug Administration commissioner.
Joseph E. Scherger is an American physician who is medical director of Restore Health –Disease Reversal in Indian Wells,California. He is the former vice president for primary care and the Marie E. Pinnizzotto,MD Chair of academic affairs at Eisenhower Medicine Center in Rancho Mirage,California. Scherger is clinical professor of family medicine at the Keck School of Medicine at the University of Southern California (USC). His main focus are nutrition and wellness,and the redesign of office practice using the tools of information technology and quality improvement.
Gerardo Jiménez Sánchez is a Mexican-born pediatrician,scientist and businessman. Along with David Valle and Barton Childs,he completed the first medical analysis of the human genome. He was founder and director of the first National Institute of Genomic Medicine in Latin America (INMEGEN) and leader of the team that developed the Genomic Map of the Mexican population.
Michelle McMurry-Heath is a medical doctor,immunologist,and from June 2020 until October 2022 served as chief executive officer for the Biotechnology Innovation Organization (BIO).